Sepsis and heart inflammation study
Part of Heart & circulation, Infections clinical trials.
This trial looks at how sepsis (a severe response to infection) affects the heart, specifically whether it causes inflammation of the heart muscle (myocarditis). It may help understand and improve care for people with sepsis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have been diagnosed with sepsis.
- You must be willing to participate and return for follow-up visits for at least one year.
- You cannot have had any heart problem before your sepsis diagnosis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how sepsis and other infections affect survival in hospitalized heart patients. It is designed for people who are being treated for a heart condition and either have no infection or have a specific type of infection or heart inflammation.
This study looks at how sepsis (a severe infection) can harm the heart in critically ill children. The goal is to better understand and manage this heart injury to improve outcomes.
This trial tests a new mathematical model to better diagnose and treat heart problems caused by sepsis. It includes adults with sepsis or septic shock who need strong blood pressure support.
This study looks at how checking heart function with an ultrasound during early sepsis treatment can help guide fluid and medication decisions. It may lead to better recovery by tailoring treatment to each patient's heart.
This study uses a special heart MRI to look closely at inflammation in the heart muscle. It helps doctors better understand and treat myocarditis and inflammatory cardiomyopathy.
This study looks at a type of immune cell called 'memory CD8+ T cells' in patients with sepsis, a life-threatening response to infection. The goal is to see if these cells are linked to how severe the sepsis is and the risk of dying. This may help doctors better predict outcomes for people with sepsis.
Hear when a new Sepsis-related Myocarditis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.